Health
New initiative identifies key parameters underlying effective anti-tumor immunity – News-Medical.Net
Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies.
Reviewed by Emily Henderson, B.Sc.Oct 9 2020
Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies. Targeting the “right” neoantigens – in a cancer vaccine or a cell therapy – has the promise to eliminate a patient’s cancer with minimal side effects. But hundreds of mutations can exist in a tumor, and only some can give rise to neoantigens that can trigger an immune response against cancer. The q…
-
General19 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
General19 hours agoWhy the nation needs the Nationals to ditch Net Zero
-
General19 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News23 hours agoBrisbane rising on global rankings, but still behind southern capitals